These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 5679193)
1. [Pharmaceutical aspect of the cost of drugs]. Mockle JA Laval Med; 1968 Jun; 39(6):477-87. PubMed ID: 5679193 [No Abstract] [Full Text] [Related]
2. [The cost of drugs]. Hamel G Laval Med; 1968 Jun; 39(6):488-94. PubMed ID: 5679194 [No Abstract] [Full Text] [Related]
3. [Unit dose packaging for Canadian hospital pharmacies--the present status]. Best JN; Digby WR Can Hosp; 1968 Oct; 45(10):83-5 passim. PubMed ID: 5687313 [No Abstract] [Full Text] [Related]
4. Drug costs and evaluation of packaging economies. Woodell J; Whitten JR Am J Hosp Pharm; 1968 Jul; 25(7):367-9. PubMed ID: 5696157 [No Abstract] [Full Text] [Related]
5. Examining the production costs of antiretroviral drugs. Pinheiro E; Vasan A; Kim JY; Lee E; Guimier JM; Perriens J AIDS; 2006 Aug; 20(13):1745-52. PubMed ID: 16931939 [TBL] [Abstract][Full Text] [Related]
6. Discriminatory pricing and packaging. Am Pharm; 1988 Sep; NS28(9):5-6. PubMed ID: 3177212 [No Abstract] [Full Text] [Related]
7. [The drug industry's viewpoint on the cost of drugs]. Doré R Laval Med; 1968 Jun; 39(6):495-505. PubMed ID: 5679195 [No Abstract] [Full Text] [Related]
9. The pharmaceutical industry -- will Canada become a major research centre? Gray C Can Med Assoc J; 1981 Apr; 124(7):910, 914-5, 918 concl. PubMed ID: 7214290 [No Abstract] [Full Text] [Related]
10. [Quality control in the pharmaceutical industry]. Sloot HA Pharm Weekbl; 1968 Apr; 103(17):506-16. PubMed ID: 5665061 [No Abstract] [Full Text] [Related]
11. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products. Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700 [No Abstract] [Full Text] [Related]
12. [Programming of production in relation to that of sales and supplies. II]. Bellentani L Boll Chim Farm; 1970 May; 109(5):283-305 contd. PubMed ID: 5454983 [No Abstract] [Full Text] [Related]
13. Drug packaging. Doyle DJ CMAJ; 1997 Mar; 156(6):764-5. PubMed ID: 9084377 [No Abstract] [Full Text] [Related]
14. Assessment of vendors and drug-product selection. Dedrick SC; Eckel FM Am J Hosp Pharm; 1984 Apr; 41(4):703-8. PubMed ID: 6720713 [TBL] [Abstract][Full Text] [Related]
15. Short communication: a study on the packaging information of essential drug products used at Union and Thana health complex level in Bangladesh. Amran S; Ahmed M; Shaheen SM; Morshed SN; Khandakar J; Rahman M; Rahman M; Hossain A Pak J Pharm Sci; 2007 Oct; 20(4):327-32. PubMed ID: 17604258 [TBL] [Abstract][Full Text] [Related]
16. [The psychological aspect of the cost of drugs]. Trottier M Laval Med; 1968 Jun; 39(6):506-11. PubMed ID: 5679196 [No Abstract] [Full Text] [Related]
17. Drug firms and regulatory agencies must consider how drugs are used. Hitchen L BMJ; 2008 Oct; 337():a2083. PubMed ID: 18854364 [No Abstract] [Full Text] [Related]
18. Psychotropic drug labeling: regulatory, pharmaceutical industry, and clinical issues and perspectives. A pharmaceutical industry perspective on drug labeling. Robinson DS Psychopharmacol Bull; 1994; 30(1):23-5. PubMed ID: 7972625 [No Abstract] [Full Text] [Related]
19. Spurious and counterfeit drugs: a growing industry in the developing world. Gautam CS; Utreja A; Singal GL Postgrad Med J; 2009 May; 85(1003):251-6. PubMed ID: 19520877 [TBL] [Abstract][Full Text] [Related]
20. An integrated pharmacist-nurse approach to the unit-dose concept. Beste DF Am J Hosp Pharm; 1968 Aug; 25(8):397-407. PubMed ID: 5673091 [No Abstract] [Full Text] [Related] [Next] [New Search]